5 results  1 of 1 

1 Evaluation of follow-up observation using human epididymis protein 4, a tumor marker, in patients with ovarian cancer
Masaya Uno, Rie Matsuo, Naoki Maezawa, Tomoyasu Kato
Obstet Gynecol Sci.2023;66(4):290-299.   Published online 2023 July 15     DOI: http://dx.doi.org/10.5468/ogs.23024
      
2 The power of the Risk of Ovarian Malignancy Algorithm considering menopausal status: a comparison with CA 125 and HE4
Kyung Hee Han, Noh Hyun Park, Jin Ju Kim, Sunmie Kim, Hee Seung Kim, Maria Lee, Yong Sang Song
J Gynecol Oncol.2019;30(6):e83.  Published online 2019 May 20     DOI: http://dx.doi.org/10.3802/jgo.2019.30.e83
      
3 Clinical Usefulness of Human Epididymis Protein 4 in Lung Cancer
Soo In Choi, Mi-Ae Jang, Byung Ryul Jeon, Hee Bong Shin, You Kyoung Lee, Yong-Wha Lee
Ann Lab Med.2017;37(6):526-530.   Published online 2017 August 16     DOI: http://dx.doi.org/10.3343/alm.2017.37.6.526
      
4 Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women
Hye Yon Cho, Sung Ho Park, Young Han Park, Hong Bae Kim, Jung Bae Kang, Seung Hwa Hong, Min Sun Kyung
J Korean Med Sci.2015;30(12):1777-1783.   Published online 2015 November 30     DOI: http://dx.doi.org/10.3346/jkms.2015.30.12.1777
      
5 Clinical efficacy of serum human epididymis protein 4 as a diagnostic biomarker of ovarian cancer: A pilot study
Shin Hye Chung, Soo Yoon Lee, Woong Ju, Seung Cheol Kim
Obstet Gynecol Sci.2013;56(4):234-241.   Published online 2013 July 15     DOI: http://dx.doi.org/10.5468/ogs.2013.56.4.234
      

 1 of 1